people
Researchers from InfraVis and MAX IV are developing virtual environments from CAD drawings for education, training, and virtual experiments. Using Blender and Unreal Engine 5, the team optimizes complex geometries for immersive visualization of beamlines like ForMAX at MAX IV. Future work focuses on topology optimization for seamless VR experiences.
The InfraVis node at Lund University has developed an application and workflow to visualize tomographic datasets in the immersive CAVE system at the Virtual Reality laboratory at LTH – Faculty of Engineering. The workflow was originally made for the LINXS hackathon SynchroMage: 3D Tomography and Visualisation for Earth’s Hidden Treasures – Environment and Climate theme, but after a positive evaluation from participants, also described in the following LINXS article, we have kept the development going.
Time: October 22-23, 2024; LINXS – Institute of Advanced Neutron and X-ray Science, IDEON Delta 5, Floor 5, Scheelevägen 19, 223 70 Lund, Sweden
Time: 13-15:30, March 14, 2024; Lund University, Sölvegatan 18, Lund, Sweden
Time: February 29, 2024; Copenhagen University, Frederiksberg Campus, Festauditoriet A1-01.01, Bülowsvej 17, 1870 Frederiksberg C, Copenhagen, Denmark
LU-IPA, previously CIPA, is the Lund University infrastructure for Image Processing and Analysis.
LU-IPA provides services for image processing and analysis, guidance and tutorial to software, access to computer work stations with image processing and analysis software, access to on-site application expertise and tools.
Lund University Bioimaging Centre (LBIC) is a resource of unique technologies and expertise available to preclinical and clinical research groups at Lund University, Region Skåne as well as external organizations and companies. LBIC is housing a large variety of advanced preclinical and clinical imaging equipment and techniques ranging from micro to macro.
Application Expert
Epilepsies are a family of devastating disorders characterized by spontaneous, recurrent seizures. It is one of the most common brain disorders and considered the most burdensome neurologic disorder worldwide. Available pharmacological treatments are only symptomatic, often with side effects and fail to adequately control seizures in one third of patients.
